Skip to content

Biogen BIIB Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$2.48B+8.7%$2.28B-10.1%$2.53B-4.2%$2.65B+8.8%$2.43B-1.0%
$661M+33.4%$495.5M-26.5%$674.4M+11.5%$605M-3.9%$629.3M+7.8%
$1.82B+1.8%$1.78B-4.1%$1.86B-8.8%$2.04B+13.3%$1.8B-3.7%
73.3%-4.9pp78.3%+4.9pp73.4%-3.7pp77.1%+3.0pp74.1%-2.1pp
$539M+5.8%$509.4M+16.8%$436.1M+9.3%$399M-8.1%$434.1M-15.4%
$607.3M-11.0%$682.5M+14.7%$594.8M+1.9%$583.8M+2.0%$572.5M-15.8%
$84M$75.3M+0.5%$74.9M-7.5%$81M
$204.4M+2.1%$200.2M-1.0%$202.2M+4.1%$194.3M+6.1%$183.2M-0.4%
$7.9M+19.7%$6.6M-10.8%$7.4M+1,157%-$700K-102%$35.3M+566%
$0$0$0$0$0
-$19.7M-$34.1M+30.0%-$48.7M+28.8%-$68.4M
$2.1B-10.1%$2.34B+18.1%$1.98B+4.0%$1.9B-10.3%$2.12B-2.0%
$67.6M$67.4M-7.2%$72.6M+21.0%$60M
$37.9M$31.6M-2.2%$32.3M+35.1%$23.9M
-$1.1M+99.7%-$317.6M-2,110%$15.8M+579%-$3.3M-232%$2.5M+101%
-$22.3M$3.8M+172%-$5.3M-115%$35.6M
$377.7M$0-100%$557.3M-25.1%$744M+139%$311.2M+6.8%
$58.2M$0-100%$90.8M-16.8%$109.2M+54.5%$70.7M+185%
$319.5M$0-100%$466.5M-26.5%$634.8M+164%$240.5M-9.8%
12.9%+12.9pp0%-18.4pp18.4%-5.6pp24%+14.1pp9.9%-1.0pp
$2.15$0.00-100%$3.17-26.8%$4.33+164%$1.64-10.4%
$2.17$0.00-100%$3.18-26.6%$4.33+162%$1.65-9.8%
148.4M+0.9%147.1M0.0%147.1M+0.3%146.7M+0.1%146.6M+0.5%
147.2M+0.5%146.5M-0.1%146.6M+0.1%146.5M+0.3%146.1M+0.3%
$88.1M$78.4M+0.4%$78.1M-7.1%$84.1M
$17.2M$20.2M-38.6%$32.9M+26.1%$26.1M
$87.8M$78.4M+0.4%$78.1M-7.1%$84.1M
$136.5M-0.1%$136.6M+0.7%$135.7M+3.7%$130.9M+17.1%$111.8M-26.1%
$107.6M$61.5M+17.1%$52.5M+2.1%$51.4M
$20.5M$5.6M-57.6%$13.2M+37.5%$9.6M
$392.2M$1.11B+1,101%$92.2M-51.2%$189M
$72.55M0.0%$72.55M0.0%$72.55M0.0%$72.55M+14.1%
$74.2M$87.2M+16.3%$75M+29.1%$58.1M
$361.3M$489.8M-14.3%$571.2M+182%$202.2M
$905M$869.6M-6.5%$930.1M+5.6%$881M
$23.6M-85.9%$166.9M-34.2%$253.8M+911%-$31.3M-12.6%-$27.8M+52.4%
$67.9M$66.5M-0.6%$66.9M-6.3%$71.4M
-$18M$68.3M+99.1%$34.3M
$0.15$0.16+10.9%$0.15-35.2%$0.23
$3.8M$3.1M-3.1%$3.2M+3.2%$3.1M
$16.5M$14.4M-3.4%$14.9M-6.9%$16M
-$3.2M$7M$0+100%-$5.4M
$20.5M+133%-$62M-1,207%$5.6M-57.6%$13.2M+37.5%$9.6M+119%
-$6.5M-$10.3M+1.0%-$10.4M-374%$3.8M
-$18.8M$500K+102%-$27.7M-460%$7.7M
-$2.4M$6.4M+93.9%$3.3M
$209.8M
$18.4M+109%-$194M+15.4%-$229.4M+62.0%-$603.8M-974%$69.1M+321%
-$243.2M-219%$203.8M-28.7%$286M+1,671%-$18.2M+93.9%-$300.5M-376%
$19M-$500K-$40.9M
-$116.2M-495%$29.4M+297%$7.4M-91.8%$89.9M+245%-$62M-193%
$89M$104.4M+375%$22M-58.9%$53.5M
100%100%
$4.8M$7M-4.1%$7.3M
$4.7M$3M
-$43.8M+68.0%-$137M-5.2%-$130.2M-1,013%-$11.7M+49.1%-$23M
-$209.5M+83.0%-$1.23B-3,409%-$35.1M+38.4%-$57M-20.5%-$47.3M-154%
$645.5M+26.1%$511.9M-59.8%$1.27B+691%$160.9M-37.9%$259.3M-65.9%
11
220.0%20.0%2
$21.1M$3.1M+104%-$78.2M-179%-$28M
$13.23M0.0%$13.23M0.0%$13.23M0.0%$13.23M
-$1.8M$0
$52.6M$26.5M+125%-$105.8M-83.0%-$57.8M
-$8.5M-$3.2M-108%$41.6M+118%$19.1M
$41.8M$23.3M+137%-$63.6M-66.1%-$38.3M
$41.8M$23.3M+137%-$63.6M-66.1%-$38.3M
$500K$0+100%-$600K-50.0%-$400K
-$28M-47.4%-$19M+42.9%-$33.3M-258%-$9.3M-38.8%-$6.7M+89.6%
-$1.1M$15.8M+579%-$3.3M-232%$2.5M
-$19.7M-$34.1M+30.0%-$48.7M+28.8%-$68.4M
$200K+101%-$22.7M+55.3%-$50.8M-267%$30.4M+15,100%$200K-33.3%
$55.1M$24.3M
$388.8M$734.2M+6.9%$686.7M+97.3%$348M
$533.2M$64.2M-41.6%$109.9M-74.3%$428.1M
$748.8M-35.9%$1.17B$0
$35M$0
$0-100%$16.3M+208%$5.3M$0-100%$10M-63.0%
$51.2M+16.6%$43.9M-5.0%$46.2M+73.7%$26.6M-28.3%$37.1M-5.6%
$11.3M$6.2M$1.3M
$625.2M$0
$51M
$500K$56.6M$0$0
$22.3M-$3.8M-172%$5.3M+115%-$35.6M
-$20.7M-$20.2M-38.4%-$14.6M-242%$10.3M
$25M$50M0.0%$50M0.0%$50M
$117.95M0.0%$117.95M0.0%$117.95M0.0%$117.95M+667%
$539M+5.8%$509.4M+16.8%$436.1M+9.3%$399M-8.1%$434.1M-15.4%
$34M$2.1M-95.5%$46.6M-76.8%$200.7M
$84M+40.9%$59.6M-20.8%$75.3M+0.5%$74.9M-7.5%$81M+7.9%
$84M$75.3M+0.5%$74.9M-7.5%$81M
-$70.3M-$1.2M-50.0%-$800K+98.0%-$39.5M
$15.2M$6.5M-5.8%$6.9M-54.6%$15.2M
$600K$100K-85.7%$700K
-$14.7M-$61.9M+15.6%-$73.3M
$9.7M$17.9M$0
$24.4M$79.8M+8.9%$73.3M
$1.2M$500K+150%$200K-60.0%$500K
$649.7M+225%$200.2M-75.8%$826.9M-18.2%$1.01B+82.3%$554.4M+16.6%
26.2%+17.4pp8.8%-23.8pp32.6%-5.6pp38.2%+15.4pp22.8%+3.4pp
$445.3M$0-100%$624.7M-23.5%$816.6M+120%$371.2M+27.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Biogen's revenue?
Biogen (BIIB) generated $9.9B in revenue over the trailing twelve months, up 1.2% year over year.
Is Biogen profitable?
Biogen reported $1.4B in net income over the trailing twelve months, a 14.3% net margin.
What are Biogen's profit margins?
Gross margin is 75.5% and operating margin is 22.9%, with a 14.3% net margin.
What is Biogen's earnings per share?
Biogen's diluted EPS over the trailing twelve months is $9.65.
Where does Biogen's income statement data come from?
Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.